Drug General Information
Drug ID
D0M9UG
Former ID
DNC007487
Drug Name
KNI-10368
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528767]
Structure
Download
2D MOL

3D MOL

Formula
C37H45N5O6S2
Canonical SMILES
CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)CC3<br />=CC(=CC=C3)N)O)C(=O)NC4C(CC5=CC=CC=C45)O)C
InChI
1S/C37H45N5O6S2/c1-37(2)33(35(47)41-31-26-15-8-7-13-24(26)19-29(31)43)42(21-50-37)36(48)32(45)27(17-22-10-5-4-6-11-22)40-34(46)28(20-49-3)39-30(44)18-23-12-9-14-25(38)16-23/h4-16,27-29,31-33,43,45H,17-21,38H2,1-3H3,(H,39,44)(H,40,46)(H,41,47)/t27-,28-,29+,31-,32-,33+/m0/s1
InChIKey
OSOTUWUUAVSXOF-ACUZRORGSA-N
PubChem Compound ID
Target and Pathway
Target(s) Plasmepsin 2 Target Info Inhibitor [528767]
References
Ref 528767Bioorg Med Chem Lett. 2007 Jun 1;17(11):3048-52. Epub 2007 Mar 21.Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
Ref 528767Bioorg Med Chem Lett. 2007 Jun 1;17(11):3048-52. Epub 2007 Mar 21.Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.